Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) Equity Ratio (2016 - 2025)

Kiora Pharmaceuticals' Equity Ratio history spans 11 years, with the latest figure at 0.66 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 5.82% year-over-year to 0.66; the TTM value through Dec 2025 reached 0.66, down 5.82%, while the annual FY2025 figure was 0.66, 5.82% down from the prior year.
  • Equity Ratio reached 0.66 in Q4 2025 per KPRX's latest filing, down from 0.75 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.82 in Q1 2024 to a low of 0.0 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.64, with a median of 0.69 recorded in 2025.
  • Peak YoY movement for Equity Ratio: plummeted 100.36% in 2021, then surged 25465.58% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.72 in 2021, then fell by 17.75% to 0.6 in 2022, then dropped by 25.2% to 0.45 in 2023, then skyrocketed by 58.46% to 0.71 in 2024, then fell by 5.82% to 0.66 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Equity Ratio are 0.66 (Q4 2025), 0.75 (Q3 2025), and 0.69 (Q2 2025).